🔖
Cite This Article
KÖKLÜ, H., KÖKLÜ, S., ÖZTÜRK, Ö. (2016). DR-70 immunoassay in gastric cancer. Turkish Journal of Gastroenterology, Cilt: 27 - Sayı: 1, 88–88. https://ajindex.com/articles/410745
Journals / Turkish Journal of Gastroenterology / 2016 / Cilt: 27 - Sayı: 1
DR-70 immunoassay in gastric cancer
- Pages
- 88–88
- DOI
- —
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗References (4)
- Morabito A, Carillio G, Longo R. Systemic treatment of gastric cancer. Crit Rev Oncol Hematol 2009; 70: 216-34.
- Lai IR, Lee WJ, Huang MT, Lin HH. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence. Hepatogastroen- terology 2002; 49: 1157-60.
- Arhan M, Yılmaz H, Önal İK, Kocabıyık M, Erdal H, İbiş M. DR-70 as a novel diagnostic biomarker for gastric cancer. Turk J Gastroenterol 2015; 26: 480-3. Tripodi A. D-dimer testing in laboratory practice. Clin Chem 2011; 57: 1256-62.
- Wu D, Zhou X, Yang G, et al. Clinical performance of the AMDL DR-70 immunoassay kit for cancer detection. J Im- munoassay 1998; 19: 63-72.